<SEC-DOCUMENT>0001214659-23-005116.txt : 20230410
<SEC-HEADER>0001214659-23-005116.hdr.sgml : 20230410
<ACCEPTANCE-DATETIME>20230410060055
ACCESSION NUMBER:		0001214659-23-005116
CONFORMED SUBMISSION TYPE:	PX14A6G
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230410
DATE AS OF CHANGE:		20230410
EFFECTIVENESS DATE:		20230410

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0101

	FILING VALUES:
		FORM TYPE:		PX14A6G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		23809590

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vermont Pension Investment Commission
		CENTRAL INDEX KEY:			0001920124
		IRS NUMBER:				203300812

	FILING VALUES:
		FORM TYPE:		PX14A6G

	BUSINESS ADDRESS:	
		STREET 1:		6 BALDWIN STREET
		CITY:			MONTPELIER
		STATE:			VT
		ZIP:			05633
		BUSINESS PHONE:		8024613595

	MAIL ADDRESS:	
		STREET 1:		6 BALDWIN STREET
		CITY:			MONTPELIER
		STATE:			VT
		ZIP:			05633
</SEC-HEADER>
<DOCUMENT>
<TYPE>PX14A6G
<SEQUENCE>1
<FILENAME>j47231px14a6g.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Thomas Golonka</B></FONT></P>
                                            <P STYLE="margin-top: 0; margin-bottom: 0">VPIC Chair<FONT STYLE="font: small-caps 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P></TD>
    <TD STYLE="text-align: center; width: 34%">&nbsp;<IMG SRC="stofv_logo.jpg" ALT=""></TD>
    <TD STYLE="width: 33%; font-size: 10pt; text-align: right"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Kimberly Gleason</B></FONT></P>
                                                               <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps">VPIC
Vice-Chair</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-variant: small-caps">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>State
of Vermont</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Vermont
Pension Investment Commission</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 7, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Johnson &amp; Johnson Shareholders,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>We are writing to urge Johnson &amp; Johnson shareholders (J&amp;J)
to VOTE FOR proposal 7 on the 2023 proxy ballot at the Company&rsquo;s Annual Stockholders Meeting on April 27, 2023. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Proposal asks the Company to stop excluding legal or compliance
costs when adjusting metrics to calculate senior executive incentive compensation awards. The proposal allows the Board discretion to
opt out of the policy when conditions warrant.</B>&nbsp;The proposal states, &ldquo;<FONT STYLE="background-color: white">The Board shall
have discretion to modify the application of this policy in specific circumstances for reasonable exceptions and in that case shall provide
a statement of explanation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Vermont Pension Investment Commission (VPIC) submitted the proposal
with the support of the Investors for Opioid and Pharmaceutical Accountability (IOPA) in response to how the Company calculates metrics
for determining senior executives&rsquo; compensation awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The IOPA, a coalition of 67 members representing treasurers, comptrollers,
asset managers, faith-based, public and union funds with more than $4.2 trillion in assets under management and advisement, began taking
note of J&amp;J&rsquo;s practice of excluding opioid-related legal costs in 2017. The IOPA has been tracking corporate actions to hold
senior executives accountable for decision-making on how firms managed their impact on the opioid crisis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The opioid crisis has led to 932,000 deaths since 1999.<SUP>1</SUP>&nbsp;Seventy-five
percent of the nearly 92,000 drug overdose deaths in 2000 involved an opioid.<SUP>2</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J&amp;J manufactured the prescription opioids NUCYNTA and DURAGESIC
through its pharmaceutical subsidiary, Janssen,<SUP>3</SUP>&nbsp;and until 2016, the Company supplied approximately 60% of the raw opiate
ingredients used in opioids like oxycodone and codeine through its former subsidiaries Noramco and Tasmanian Alkaloids.<SUP>4</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> &ldquo;Drug Overdose Deaths,&rdquo; Centers for Disease
Control and Prevention, available at: https://www.cdc.gov/drugoverdose/deaths/index.html</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>2</SUP> Ibid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>3</SUP> In 2020, Johnson &amp; Johnson announced it would delist
and stop selling all prescription pain medicines in the U.S.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><SUP>4</SUP></FONT> h<FONT STYLE="font-size: 10pt">ttps://www.washingtonpost.com/graphics/2020/business/opioid-crisis-johnson-and-johnson-tasmania-poppy</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As J&amp;J notes in its annual report, the Company has been named in
close to 3,500 lawsuits related to the marketing of opioids, including DURAGESIC (Fentanyl), NUCYNTA, NUCYNTA ER and to the previously
owned raw opioid suppliers, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. The complaints allege false advertising, unfair competition,
public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment.<SUP>5</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J&amp;J has paid out settlements in relation to some of these claims
including $5 billion to be paid out in various amounts to states, counties and other parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Performance metrics should incentivize the right level of risk-taking.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board decisions to factor out the impact of legal settlements related
to opioids is a key indicator to investors of whether the company believes senior leadership should have skin in the game. We support
compensation arrangements that incentivize senior executives to drive growth while safeguarding company operations and reputation over
the long-term. For this reason, we take issue with the practice of adjusting out litigation expenses to insulate executives from the consequences
of their decisions and the financial penalty born by investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>The litigation expenses are significant and
the impact of the Company excluding the expenses is unclear.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">J&amp;J booked $5.1 billion in litigation expense
in 2020, $2.3 billion in 2021 and $0.9 billion in 2023.<SUP>6</SUP>&nbsp;In February, the Third Circuit Court of Appeal denied the Company&rsquo;s
attempt to manage billions of dollars of legal claims from cancer survivors alleging talcum powder caused their illnesses.<SUP>7</SUP>
In 2021, J&amp;J spun off about 40,000 talc cases into a subsidiary named LTL management that then filed for bankruptcy, a process known
as the &ldquo;Texas Two-Step.&rdquo; The Court&rsquo;s decision means J&amp;J will have a much longer and potentially more costly road
ahead to resolve talc litigation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>5</SUP>
Johnson &amp; Johnson, &ldquo;Annual report for year ending January 1, 2023,&rdquo; available at</FONT> <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040623000016/jnj-20230101.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040623000016/jnj-20230101.htm</FONT></A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><SUP>6</SUP>
Johnson &amp; Johnson, &ldquo;Annual report for year ending January 2, 2022,&rdquo; available at:&nbsp;</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/jnj-20220102.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif">https://www.sec.gov/Archives/edgar/data/200406/000020040622000022/jnj-20220102.htm</FONT></A><FONT STYLE="font-family: Times New Roman, Times, Serif">.</FONT>
Johnson &amp; Johnson, &ldquo;2023 Proxy Statement,&rdquo; available at: https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040623000023/jnj-20230313.htm#iff400f09331a48ef93883b88f0918483_277</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>7</SUP> &ldquo;Talc ruling a blow to J&amp;J and the &ldquo;Texas
two-step&rdquo; bankruptcy jig,&rdquo; Jamie Smyth, <I>Financial Times,</I> Feb. 5, 2023, available at: https://www.ft.com/content/e8eb2715-54cd-4dd0-8ca7-cc342ef49973.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The board&rsquo;s response and recommendation
and why we disagree</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The board has asked that you vote against this proposal, citing certain
recent changes and confidence in its overall approach. Below, we summarize the company&rsquo;s points and explain why they are an insufficient
response to the substance of this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">J&amp;J notes in the proxy statement that, &ldquo;<FONT STYLE="background-color: white">shareholders
expressed an interest in continued transparency around oversight of legal and compliance risks and decision-making by the Compensation
&amp; Benefits Committee (CBC) on excluding large charges from executive compensation metrics.&rdquo;<SUP>8</SUP></FONT> The company has
enhanced its disclosure, including by describing the criteria and process it uses to decide whether to include or exclude items. Further,
the board notes that shareholders have access to reconciliations of GAAP and non-GAAP items in the company&rsquo;s disclosures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>However, while disclosures have improved, they
still do not provide a rationale as to why certain legal settlements have been excluded from performance metrics, nor is there detailed
disclosure on which items have been excluded, <FONT STYLE="background-color: white">why it chooses to exclude litigation costs in particular
circumstances and the financial impact of those decisions on executive compensation payouts.</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board suggests that this proposal encroaches
on discretion of Compensation &amp; Benefits Committee. <B>However, the proposal explicitly provides discretion to the board to opt out
of the policy when conditions warrant.</B> The proposal states, &ldquo;<FONT STYLE="background-color: white">The Board shall have discretion
to modify the application of this policy in specific circumstances for reasonable exceptions and in that case shall provide a statement
of explanation.&rdquo; The Board is free to determine the circumstances for reasonable exceptions, which might include, for example, instances
where the current executives were not in place when the liabilities were incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board suggests that the proposal presents
practical challenges to company goal-setting because litigation is inherently unpredictable. With respect, litigation is not the only
unpredictable factor in goal-setting, as we have seen in the past few years. Boards have had to contend with market-shifting changes from
a global pandemic and rapid interest rate changes, to name just two unpredictable factors. Further, the time horizons for litigation allow
for considerable advance planning before settlements are reached. <B>In short, while the board may continue to manage some unpredictability,
the alternative is to sacrifice accountability for predictability, which is the worse option.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lastly,
the board suggests that the proposal could further obligate the Company to disclose competitively harmful information, such as information
on specific settlement amounts. <B>As above, the proposal explicitly states that &ldquo;<FONT STYLE="background-color: white">The Board
shall have discretion to modify the application of this policy in specific circumstances for reasonable exceptions and in that case shall
provide a statement of explanation.&rdquo;</FONT></B><FONT STYLE="background-color: white"> This could include clarification where the
specific amount of an individual settlement (as opposed to the aggregate amount for exclusions which is currently disclosed) may not be
disc</FONT></FONT><FONT STYLE="background-color: white">losed, for example when the disclosure may harm other ongoing legal settlement
discussions. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_____________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>8</SUP> Johnson &amp; Johnson, &ldquo;2023 Proxy Statement,&rdquo;
available at: https://www.sec.gov/ix?doc=/Archives/edgar/data/200406/000020040623000023/jnj-20230313.htm#iff400f09331a48ef93883b88f0918483_277.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 8pt; margin-bottom: 6pt; border-bottom: Black 2px solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 8pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 100%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J&amp;J is structuring executive pay to align with shareholder interests
on the front end but then adjusting the calculations on the back end to insulate executives from the market reality of legal and compliance
costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We support compensation arrangements that incentivize senior executives
to drive growth while safeguarding company operations and reputation over the long-term. For this reason, we take issue with the practice
of adjusting out litigation expenses to insulate executives from the consequences of their decisions and the financial penalty born by
investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We urge you to vote FOR proposal 7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>This is not a solicitation
of authority to vote your proxy. Please DO NOT send us your proxy card as it will not be accepted.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2px solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>stofv_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 stofv_logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!F17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (   $Q  (    0    3@
M      !@     0   &     !<&%I;G0N;F5T(#0N,"XU /_; $,  @$! @$!
M @(" @(" @(#!0,# P,#!@0$ P4'!@<'!P8'!P@)"PD(" H(!P<*#0H*"PP,
M# P'"0X/#0P."PP,#/_; $,! @(" P,#!@,#!@P(!P@,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( '@
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M6*JXA0YX1<5%<RV5M;K2VUOO.S/L\K4\PJ0I4W)*3U;M^C/HS_A'+<?\\?\
MOH5^-/\ P<9?%3PCXL^,&E^#X]$\1:;XX\%P+G492@TS5M.N4\TA!DLQ24*
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MO&3,%88"LJD@A@?6OKOX/V?@/PEH-C;M=Z+9:QK#KY\;3R76Z?H%$LB@CH,
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M_*9<MOYN7# @;L1@(!O-=-I?AHZQK.GZ1<ZI]C@U&$16=U9317%O>\8P&(W
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MD^'_ ,,?VR/^$HM?VAKWQSXKM=02[\^U\,_VY+J-PREC)Y$?FB:,%></D<#
M8$#S[XZ?L]_#'6_&UQ=67CW29-?;7[2TO(-6MWT>XM99KID*QK)*1'L50\AN
M!$JB1?WF<K7Z!'%4$XQM9+1:?*WH?C&/\,>(J[GBZ?)4DES.,9W:C:]]4EU=
M]?S/G_X:ZG\1+WQ=;WMEJ&KMJ!D,DB1.5FG"2C<I.#M.X9^F.V,?U5_\$UQK
MDW[$/P]N_$UK=6OB#4-.^U7PNH%AN9&9VVM*% W.8]GS'EA@DFOD7X#?!/\
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,3EZNYW5%%%4<Y__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
